Sixty-five overlapping targets were closely related to the relevant pathways of prostate cancer (hsa05215), C-type lectin receptor signaling pathway (hsa04625), TNF signaling pathway (hsa04668) and endocrine resistance (hsa01522) (Figure 4B). Here, CLEC4D is linked to prostate cancer.